DEXMEDETOMIDINE

DEXMEDETOMIDINE was reported 3462 times

DEXMEDETOMIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALVEOLAR OXYGEN PARTIAL PRESSURE INCREASED 1 0.2500
1 BLOOD BROMIDE INCREASED 5 0.2381
2 BILIARY CAST SYNDROME 2 0.2000
3 URINARY ASCITES 2 0.0952
4 TRANSCRANIAL ELECTRICAL MOTOR EVOKED POTENTIAL MONITORING ABNORMAL 3 0.0909
5 DEVICE PACING ISSUE 7 0.0824
6 NEONATAL HYPERGLYCAEMIA 3 0.0811
7 CHEST WALL RIGIDITY 5 0.0781
8 PHAEOCHROMOCYTOMA CRISIS 16 0.0755
9 ACUTE MOTOR AXONAL NEUROPATHY 7 0.0673
10 BURKHOLDERIA TEST POSITIVE 8 0.0645
11 ANAESTHETIC COMPLICATION NEUROLOGICAL 57 0.0629
12 POSTOPERATIVE DELIRIUM 12 0.0606
13 CONFUSIONAL AROUSAL 9 0.0559
14 VASCULAR ACCESS MALFUNCTION 3 0.0556
15 HYPERCATABOLISM 2 0.0526
16 JUNCTIONAL ECTOPIC TACHYCARDIA 3 0.0517
17 TRIGEMINO-CARDIAC REFLEX 4 0.0494
18 POSTOPERATIVE ILEUS 27 0.0479
19 FOETAL MEGACYSTIS 2 0.0455
20 INTENSIVE CARE UNIT DELIRIUM 2 0.0417
21 NEGATIVE PRESSURE PULMONARY OEDEMA 4 0.0408
22 MECHANICAL VENTILATION COMPLICATION 6 0.0403
23 ELECTROCARDIOGRAM R ON T PHENOMENON 2 0.0400
24 MALIGNANT CATATONIA 10 0.0380
25 CARDIAC ARREST NEONATAL 5 0.0362
26 TACHYPHYLAXIS 12 0.0344
27 HYPEREXPLEXIA 2 0.0317
28 MEAN ARTERIAL PRESSURE DECREASED 8 0.0316
29 POSTRESUSCITATION ENCEPHALOPATHY 2 0.0312
30 ABDOMINAL COMPARTMENT SYNDROME 19 0.0298
31 MEAN ARTERIAL PRESSURE INCREASED 2 0.0286
32 ELECTROCARDIOGRAM PR SHORTENED 6 0.0286
33 HYPERTHERMIA MALIGNANT 42 0.0282
34 LARYNGEAL OBSTRUCTION 5 0.0273
35 PAROXYSMAL SYMPATHETIC HYPERACTIVITY 2 0.0267
36 DIABETES INSIPIDUS 64 0.0266
37 INTESTINAL PSEUDO-OBSTRUCTION 23 0.0262
38 MYOCARDIAL CALCIFICATION 3 0.0256
39 BACTERIAL TRACHEITIS 2 0.0247
40 UNWANTED AWARENESS DURING ANAESTHESIA 8 0.0244
41 LARYNGOMALACIA 8 0.0239
42 EPIDERMOLYSIS BULLOSA 7 0.0226
43 HYPOCAPNIA 9 0.0215
44 HYPERCAPNIC COMA 3 0.0211
45 NEONATAL ANURIA 2 0.0211
46 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 8 0.0211
47 CEREBRAL SALT-WASTING SYNDROME 2 0.0202
48 URINARY BLADDER RUPTURE 5 0.0197
49 PROCEDURAL PNEUMOTHORAX 3 0.0194
50 AIRWAY COMPLICATION OF ANAESTHESIA 5 0.0190
51 DRUG-DEVICE INTERACTION 2 0.0180
52 ACID BASE BALANCE ABNORMAL 4 0.0179
53 WRONG PRODUCT STORED 5 0.0176
54 RECURRENCE OF NEUROMUSCULAR BLOCKADE 3 0.0175
55 PROPOFOL INFUSION SYNDROME 12 0.0170
56 PULMONARY VEIN STENOSIS 2 0.0169
57 UPPER AIRWAY OBSTRUCTION 15 0.0169
58 SEDATION COMPLICATION 42 0.0164
59 MATERNAL EXPOSURE DURING DELIVERY 16 0.0161
60 PERIPORTAL OEDEMA 2 0.0160
61 ECHOLALIA 5 0.0157
62 ATONIC URINARY BLADDER 3 0.0155
63 CENTRAL SLEEP APNOEA SYNDROME 5 0.0154
64 SINUS ARREST 24 0.0153
65 LOCKED-IN SYNDROME 7 0.0152
66 WITHDRAWAL HYPERTENSION 3 0.0149
67 ACQUIRED PORPHYRIA 1 0.0141
68 NEONATAL HYPOTENSION 5 0.0136
69 PULMONARY AIR LEAKAGE 2 0.0132
70 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 14 0.0132
71 AIRWAY PEAK PRESSURE INCREASED 2 0.0132
72 WITHDRAWAL CATATONIA 3 0.0130
73 PARENTERAL NUTRITION 3 0.0130
74 CLOSTRIDIAL SEPSIS 3 0.0124
75 ADRENERGIC SYNDROME 1 0.0123
76 ACUTE CHEST SYNDROME 10 0.0114
77 ACQUIRED MACROGLOSSIA 1 0.0112
78 CHEST TUBE INSERTION 2 0.0106
79 INFUSION SITE NECROSIS 2 0.0104
80 DEAFNESS PERMANENT 2 0.0102
81 SEIZURE LIKE PHENOMENA 17 0.0100
82 MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0096
83 ADHESIOLYSIS 1 0.0093
84 GLOSSOPTOSIS 2 0.0091
85 METHAEMOGLOBINAEMIA 21 0.0091
86 PARADOXICAL DRUG REACTION 31 0.0084
87 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 9 0.0082
88 HYPERDYNAMIC LEFT VENTRICLE 2 0.0081
89 NECROTISING OESOPHAGITIS 4 0.0080
90 APGAR SCORE LOW 10 0.0078
91 LEUKAEMOID REACTION 2 0.0077
92 OXYGEN SATURATION 2 0.0076
93 ENTEROCOCCAL BACTERAEMIA 8 0.0075
94 AMMONIA ABNORMAL 3 0.0074
95 SPINAL MUSCULAR ATROPHY 2 0.0074
96 DELAYED RECOVERY FROM ANAESTHESIA 7 0.0074
97 MACROGLOSSIA 4 0.0073
98 HYPERTHERMIA 55 0.0072
99 APNOEIC ATTACK 4 0.0071
100 PRODUCT PACKAGING CONFUSION 17 0.0070
101 PULMONARY ARTERIAL PRESSURE ABNORMAL 2 0.0069
102 ACCELERATED IDIOVENTRICULAR RHYTHM 1 0.0068
103 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 2 0.0065
104 DIAPHRAGMATIC HERNIA 4 0.0065
105 CEREBRAL HYPOPERFUSION 3 0.0064
106 APLASTIC ANAEMIA 33 0.0063
107 SUPERINFECTION BACTERIAL 5 0.0063
108 CEREBRAL ARTERY STENOSIS 3 0.0061
109 RESPIRATORY ALKALOSIS 10 0.0061
110 MITOCHONDRIAL TOXICITY 5 0.0061
111 VOCAL CORD DYSFUNCTION 3 0.0061
112 HYPERCAPNIA 18 0.0060
113 PNEUMONITIS ASPIRATION 2 0.0058
114 AUTONOMIC NERVOUS SYSTEM IMBALANCE 17 0.0058
115 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 2 0.0057
116 ACQUIRED DIAPHRAGMATIC EVENTRATION 2 0.0056
117 BRADYCARDIA NEONATAL 7 0.0056
118 PRODUCT NAME CONFUSION 6 0.0055
119 SYMPTOM MASKED 4 0.0055
120 ARTERIOSPASM CORONARY 22 0.0055
121 HYPERTENSIVE URGENCY 3 0.0054
122 DRUG CLEARANCE DECREASED 7 0.0054
123 ENANTHEMA 3 0.0052
124 PRODUCT BARCODE ISSUE 2 0.0052
125 WRONG DRUG 2 0.0052
126 HYPERBILIRUBINAEMIA NEONATAL 3 0.0052
127 CONGENITAL DIAPHRAGMATIC HERNIA 2 0.0051
128 ENDOTRACHEAL INTUBATION COMPLICATION 3 0.0051
129 RESPIRATORY ACIDOSIS 20 0.0051
130 TRACHEOMALACIA 2 0.0051
131 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 3 0.0051
132 HAEMATOMA MUSCLE 6 0.0050
133 TORSADE DE POINTES 39 0.0050
134 DELIRIUM TREMENS 2 0.0050
135 SPUTUM CULTURE POSITIVE 4 0.0049
136 PROCEDURAL HYPOTENSION 4 0.0047
137 OCULOGYRIC CRISIS 10 0.0047
138 KLEBSIELLA TEST POSITIVE 3 0.0046
139 SEROTONIN SYNDROME 87 0.0045
140 HEPATIC ENZYME DECREASED 2 0.0045
141 POLYURIA 36 0.0044
142 ANTICHOLINERGIC SYNDROME 7 0.0044
143 LAPAROTOMY 2 0.0044
144 DISINHIBITION 7 0.0043
145 PRODUCT APPEARANCE CONFUSION 4 0.0043
146 HAEMODYNAMIC INSTABILITY 33 0.0043
147 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0043
148 BRADYCARDIA 228 0.0043
149 ENDOTRACHEAL INTUBATION 12 0.0043
150 INTENSIVE CARE 6 0.0042
151 PRODUCT CONTAMINATION MICROBIAL 5 0.0042
152 PORPHYRIA ACUTE 6 0.0042
153 CLONUS 11 0.0040
154 CATATONIA 21 0.0040
155 BRUGADA SYNDROME 4 0.0039
156 APNOEA 30 0.0038
157 HYPERNATRAEMIA 19 0.0038
158 INFUSION SITE CELLULITIS 2 0.0038
159 STRESS CARDIOMYOPATHY 22 0.0038
160 HEART FAILURE WITH REDUCED EJECTION FRACTION 2 0.0037
161 EPIGLOTTITIS 2 0.0037
162 ARRHYTHMIA SUPRAVENTRICULAR 4 0.0037
163 DELIRIUM 126 0.0036
164 ATRIOVENTRICULAR BLOCK SECOND DEGREE 11 0.0036
165 RESPIRATORY DEPRESSION 44 0.0036
166 AGONAL RESPIRATION 1 0.0035
167 TACHYPNOEA 48 0.0035
168 MALIGNANT HYPERTENSION 3 0.0035
169 NEUROLEPTIC MALIGNANT SYNDROME 41 0.0035
170 MEDIASTINITIS 2 0.0034
171 MYOCLONUS 41 0.0034
172 VASOCONSTRICTION 3 0.0034
173 IRREGULAR BREATHING 2 0.0034
174 BRADYPNOEA 9 0.0033
175 MYOCLONIC EPILEPSY 5 0.0033
176 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 4 0.0032
177 FUNGAEMIA 5 0.0032
178 DRY GANGRENE 2 0.0031
179 HYPERCHLORAEMIA 2 0.0031
180 FOETAL DEATH 16 0.0031
181 PROCEDURAL VOMITING 2 0.0031
182 PNEUMONIA STAPHYLOCOCCAL 6 0.0030
183 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
184 LARYNGOSPASM 8 0.0030
185 FOETAL EXPOSURE DURING DELIVERY 2 0.0029
186 POSTICTAL STATE 3 0.0029
187 RECALLED PRODUCT 5 0.0029
188 INCISIONAL HERNIA 4 0.0029
189 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 27 0.0028
190 PRODUCT DESIGN ISSUE 2 0.0028
191 TRACHEOSTOMY 4 0.0028
192 TOXIC LEUKOENCEPHALOPATHY 2 0.0028
193 PRODUCT SELECTION ERROR 3 0.0027
194 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 6 0.0027
195 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 14 0.0027
196 DRUG-DISEASE INTERACTION 2 0.0027
197 DIFFERENTIATION SYNDROME 2 0.0027
198 STRIDOR 8 0.0027
199 OSMOTIC DEMYELINATION SYNDROME 2 0.0027
200 METABOLIC ENCEPHALOPATHY 8 0.0027
201 MOANING 3 0.0026
202 BLOOD FIBRINOGEN DECREASED 3 0.0026
203 CENTRAL NERVOUS SYSTEM INFECTION 3 0.0026
204 HYPOPNOEA 9 0.0026
205 HYPERTRANSAMINASAEMIA 18 0.0026
206 GRIMACING 2 0.0026
207 RESTRICTIVE PULMONARY DISEASE 3 0.0026
208 TRANSPOSITION OF THE GREAT VESSELS 2 0.0026
209 HYPORESPONSIVE TO STIMULI 3 0.0026
210 TYPE IV HYPERSENSITIVITY REACTION 7 0.0026
211 GASTROINTESTINAL STOMA COMPLICATION 4 0.0025
212 RASH MORBILLIFORM 7 0.0025
213 MACULE 7 0.0025
214 LONG QT SYNDROME 6 0.0025
215 PROCEDURAL NAUSEA 2 0.0025
216 PERFORATION 2 0.0025
217 SINUS BRADYCARDIA 24 0.0025
218 PNEUMATOSIS INTESTINALIS 7 0.0025
219 INFANTILE APNOEA 2 0.0025
220 BRADYARRHYTHMIA 4 0.0024
221 DIVERTICULAR PERFORATION 5 0.0024
222 CATHETER SITE HAEMORRHAGE 6 0.0024
223 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
224 ALCOHOL WITHDRAWAL SYNDROME 2 0.0023
225 ENTEROCUTANEOUS FISTULA 2 0.0023
226 CARDIAC OUTPUT DECREASED 2 0.0023
227 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
228 INTESTINAL DILATATION 3 0.0022
229 PRODUCT LABEL CONFUSION 13 0.0022
230 VENOOCCLUSIVE LIVER DISEASE 11 0.0022
231 ANAEMIA OF CHRONIC DISEASE 2 0.0022
232 HYPERAESTHESIA 18 0.0022
233 GENERALISED TONIC-CLONIC SEIZURE 36 0.0022
234 PNEUMOPERITONEUM 4 0.0022
235 FOETAL HEART RATE ABNORMAL 2 0.0022
236 DEAFNESS NEUROSENSORY 7 0.0021
237 AIR EMBOLISM 1 0.0021
238 CEREBELLAR HAEMORRHAGE 3 0.0021
239 AGITATION 153 0.0021
240 HYPOTHERMIA 21 0.0021
241 HYPERVENTILATION 12 0.0021
242 NODAL RHYTHM 3 0.0020
243 DUODENAL PERFORATION 2 0.0020
244 ELECTROCARDIOGRAM QT PROLONGED 73 0.0020
245 ACUTE PSYCHOSIS 5 0.0020
246 BRAIN STEM INFARCTION 2 0.0020
247 STATUS EPILEPTICUS 22 0.0019
248 REBOUND EFFECT 22 0.0019
249 HYPOXIA 68 0.0019
250 VENTRICULAR DYSFUNCTION 5 0.0019
251 POST LUMBAR PUNCTURE SYNDROME 2 0.0019
252 HYPOTONIA NEONATAL 3 0.0019
253 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0019
254 COGWHEEL RIGIDITY 2 0.0019
255 ENTEROCOLITIS 11 0.0019
256 LOW BIRTH WEIGHT BABY 15 0.0019
257 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
258 BLOOD SODIUM ABNORMAL 2 0.0019
259 METABOLIC ALKALOSIS 3 0.0019
260 STUPOR 6 0.0019
261 HYPERLACTACIDAEMIA 5 0.0019
262 HYPERPHOSPHATAEMIA 4 0.0019
263 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 102 0.0019
264 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 11 0.0019
265 VASOPLEGIA SYNDROME 3 0.0018
266 PILOERECTION 2 0.0018
267 CARDIAC ARREST 150 0.0018
268 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
269 ILLUSION 3 0.0018
270 INTERCEPTED PRODUCT DISPENSING ERROR 3 0.0018
271 MYOCARDIAL INJURY 2 0.0018
272 WRONG PRODUCT ADMINISTERED 12 0.0018
273 DEAFNESS BILATERAL 3 0.0018
274 WITHDRAWAL SYNDROME 74 0.0018
275 THYROTOXIC CRISIS 2 0.0018
276 RESPIRATORY FAILURE 128 0.0018
277 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
278 SICK SINUS SYNDROME 2 0.0017
279 CEREBRAL VENTRICLE DILATATION 2 0.0017
280 NEPHROGENIC DIABETES INSIPIDUS 2 0.0017
281 HYPERREFLEXIA 6 0.0017
282 GROIN ABSCESS 2 0.0017
283 ACUTE RESPIRATORY DISTRESS SYNDROME 30 0.0017
284 NEPHROCALCINOSIS 2 0.0017
285 DRUG WITHDRAWAL CONVULSIONS 3 0.0017
286 PRODUCT CONTAMINATION 6 0.0017
287 MIXED LIVER INJURY 5 0.0017
288 VENTRICULAR ARRHYTHMIA 6 0.0016
289 VENTRICULAR TACHYCARDIA 27 0.0016
290 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
291 MULTIPLE-DRUG RESISTANCE 5 0.0016
292 ACUTE PULMONARY OEDEMA 9 0.0016
293 TROPONIN T INCREASED 2 0.0016
294 ACIDOSIS 12 0.0016
295 ACUTE RESPIRATORY FAILURE 30 0.0016
296 PNEUMONIA CYTOMEGALOVIRAL 3 0.0015
297 INTERCEPTED PRODUCT SELECTION ERROR 2 0.0015
298 ANAEMIA POSTOPERATIVE 2 0.0015
299 ENCEPHALITIS AUTOIMMUNE 2 0.0015
300 BLOOD LACTIC ACID INCREASED 8 0.0015
301 LUNG OPACITY 4 0.0015
302 POTENTIATING DRUG INTERACTION 5 0.0015
303 MENTAL STATUS CHANGES 41 0.0015
304 PULSE ABSENT 7 0.0015
305 ISCHAEMIC HEPATITIS 2 0.0015
306 ANASTOMOTIC LEAK 1 0.0014
307 MAST CELL ACTIVATION SYNDROME 2 0.0014
308 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
309 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
310 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
311 MUSCLE RIGIDITY 17 0.0014
312 ANTIPSYCHOTIC DRUG LEVEL INCREASED 4 0.0014
313 CARDIOGENIC SHOCK 20 0.0014
314 HAEMOTHORAX 4 0.0014
315 MUTISM 2 0.0014
316 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 2 0.0014
317 PULMONARY SEPSIS 2 0.0014
318 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
319 NEUROTOXICITY 24 0.0014
320 PULMONARY VALVE INCOMPETENCE 2 0.0014
321 CLOSTRIDIUM TEST POSITIVE 3 0.0014
322 MYASTHENIA GRAVIS CRISIS 2 0.0013
323 AMINO ACID LEVEL INCREASED 1 0.0013
324 COLITIS ISCHAEMIC 9 0.0013
325 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 10 0.0013
326 BLOOD LOSS ANAEMIA 3 0.0013
327 METASTASES TO MENINGES 3 0.0013
328 DERMATITIS ACNEIFORM 8 0.0013
329 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
330 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
331 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
332 MYOGLOBIN BLOOD INCREASED 2 0.0013
333 NEUROLOGICAL DECOMPENSATION 3 0.0013
334 ILEUS 16 0.0013
335 SUBSTANCE USE 2 0.0013
336 ASPIRATION 14 0.0013
337 RESPIRATORY RATE DECREASED 4 0.0013
338 MULTIPLE ORGAN DYSFUNCTION SYNDROME 36 0.0013
339 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
340 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
341 HYPOVOLAEMIC SHOCK 6 0.0013
342 AZOTAEMIA 5 0.0013
343 VENTRICULAR HYPOKINESIA 4 0.0012
344 ATELECTASIS 12 0.0012
345 PORTAL VEIN THROMBOSIS 4 0.0012
346 HYPOVENTILATION 4 0.0012
347 PERIPHERAL ISCHAEMIA 5 0.0012
348 ENCEPHALOPATHY 30 0.0012
349 INFLAMMATORY MARKER INCREASED 6 0.0012
350 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
351 QUADRIPARESIS 2 0.0012
352 HYPOTONIA 12 0.0012
353 CARDIAC FAILURE ACUTE 8 0.0012
354 TROPONIN I INCREASED 2 0.0012
355 PULSELESS ELECTRICAL ACTIVITY 5 0.0012
356 HYPERTRIGLYCERIDAEMIA 7 0.0012
357 DRUG INTERACTION 189 0.0012
358 DYSPHORIA 6 0.0012
359 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
360 HEPATORENAL SYNDROME 2 0.0012
361 SEDATION 31 0.0012
362 CANCER PAIN 3 0.0012
363 VENTRICULAR FIBRILLATION 13 0.0012
364 UNRESPONSIVE TO STIMULI 30 0.0012
365 CHOREA 2 0.0012
366 TACHYCARDIA 103 0.0012
367 BLOOD CHLORIDE INCREASED 2 0.0012
368 PULMONARY HAEMORRHAGE 9 0.0011
369 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
370 URINE OUTPUT INCREASED 3 0.0011
371 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
372 SERUM FERRITIN INCREASED 6 0.0011
373 ABDOMINAL SEPSIS 1 0.0011
374 ABDOMINAL ABSCESS 5 0.0011
375 PREMATURE DELIVERY 18 0.0011
376 NEONATAL RESPIRATORY DISTRESS SYNDROME 4 0.0011
377 MIOSIS 9 0.0011
378 TRANSPLANT DYSFUNCTION 2 0.0011
379 ANAESTHETIC COMPLICATION 3 0.0011
380 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
381 PRODUCT TAMPERING 2 0.0011
382 HYDROCEPHALUS 6 0.0011
383 COVID-19 PNEUMONIA 13 0.0011
384 BACTERAEMIA 13 0.0011
385 DRUG DOSE TITRATION NOT PERFORMED 2 0.0011
386 OPPORTUNISTIC INFECTION 2 0.0011
387 HYPOTENSION 216 0.0011
388 DRUG TOLERANCE DECREASED 3 0.0011
389 MECHANICAL VENTILATION 2 0.0011
390 RESPIRATORY DISTRESS 29 0.0010
391 HYPOREFLEXIA 2 0.0010
392 TRAUMATIC LUNG INJURY 2 0.0010
393 SEPTIC SHOCK 45 0.0010
394 CONVERSION DISORDER 2 0.0010
395 HYPOVOLAEMIA 6 0.0010
396 APLASIA 2 0.0010
397 COLOSTOMY 2 0.0010
398 RESPIRATION ABNORMAL 7 0.0010
399 BRAIN HERNIATION 3 0.0010
400 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
401 PREMATURE BABY 30 0.0010
402 FOAMING AT MOUTH 2 0.0010
403 PNEUMONIA BACTERIAL 9 0.0010
404 INTESTINAL PERFORATION 11 0.0010
405 DYSTONIA 19 0.0010
406 IMMUNE-MEDIATED HEPATITIS 2 0.0010
407 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
408 QUADRIPLEGIA 2 0.0010
409 METABOLIC ACIDOSIS 31 0.0010
410 SHOCK 22 0.0010
411 DILATATION VENTRICULAR 2 0.0010
412 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
413 MUCOSAL INFLAMMATION 24 0.0009
414 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
415 HYPOALBUMINAEMIA 7 0.0009
416 HYPERTENSIVE CRISIS 10 0.0009
417 LARGE INTESTINAL OBSTRUCTION 2 0.0009
418 QUALITY OF LIFE DECREASED 12 0.0009
419 CHOLESTASIS 17 0.0009
420 LIVER FUNCTION TEST INCREASED 19 0.0009
421 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
422 DRUG WITHDRAWAL SYNDROME NEONATAL 13 0.0009
423 DRUG WITHDRAWAL SYNDROME 77 0.0009
424 PANCREATITIS NECROTISING 2 0.0009
425 HYPERBILIRUBINAEMIA 9 0.0009
426 DROOLING 6 0.0009
427 VENTRICULAR EXTRASYSTOLES 9 0.0009
428 LARGE INTESTINE PERFORATION 6 0.0009
429 UMBILICAL HERNIA 4 0.0009
430 HANGOVER 3 0.0009
431 CYTOKINE RELEASE SYNDROME 17 0.0008
432 THERAPY PARTIAL RESPONDER 13 0.0008
433 GASTROINTESTINAL OBSTRUCTION 2 0.0008
434 PREMATURE RUPTURE OF MEMBRANES 2 0.0008
435 ENTEROCOCCAL INFECTION 4 0.0008
436 MONOCYTE COUNT INCREASED 3 0.0008
437 THERAPY NON-RESPONDER 37 0.0008
438 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
439 PULMONARY HYPERTENSION 17 0.0008
440 HEPATOMEGALY 8 0.0008
441 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
442 RETROPERITONEAL HAEMORRHAGE 2 0.0008
443 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
444 DEVICE INFUSION ISSUE 2 0.0008
445 CARDIAC DYSFUNCTION 3 0.0008
446 SMALL FOR DATES BABY 4 0.0008
447 LEUKOENCEPHALOPATHY 3 0.0008
448 OLIGURIA 5 0.0008
449 RETINOPATHY 3 0.0008
450 PNEUMONIA ASPIRATION 20 0.0008
451 VENOOCCLUSIVE DISEASE 2 0.0008
452 DRUG TOLERANCE 4 0.0008
453 TOXIC ENCEPHALOPATHY 4 0.0008
454 TROPONIN INCREASED 6 0.0008
455 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
456 PETIT MAL EPILEPSY 4 0.0008
457 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
458 ADENOCARCINOMA PANCREAS 1 0.0008
459 LIPOMA 2 0.0008
460 MUCORMYCOSIS 2 0.0008
461 PARTIAL SEIZURES 4 0.0008
462 CIRCULATORY COLLAPSE 13 0.0008
463 PNEUMOTHORAX 12 0.0008
464 BLOOD SODIUM INCREASED 2 0.0007
465 ABDOMINAL RIGIDITY 2 0.0007
466 NORMAL NEWBORN 4 0.0007
467 HICCUPS 6 0.0007
468 ACCIDENTAL POISONING 1 0.0007
469 MATERNAL EXPOSURE DURING PREGNANCY 65 0.0007
470 THROMBOTIC MICROANGIOPATHY 7 0.0007
471 LIVE BIRTH 6 0.0007
472 MALNUTRITION 8 0.0007
473 PULMONARY OEDEMA 32 0.0007
474 RIGHT VENTRICULAR FAILURE 5 0.0007
475 HYPERPYREXIA 3 0.0007
476 LIP OEDEMA 3 0.0007
477 DELUSION 11 0.0007
478 HYPERTONIA 4 0.0007
479 BRAIN INJURY 7 0.0007
480 ANURIA 6 0.0007
481 MYOPATHY 6 0.0007
482 LIVER INJURY 17 0.0007
483 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
484 EXPOSURE DURING PREGNANCY 43 0.0007
485 CHAPPED LIPS 3 0.0007
486 COMA SCALE ABNORMAL 2 0.0007
487 ESCHERICHIA SEPSIS 2 0.0007
488 ADENOVIRUS INFECTION 2 0.0007
489 RALES 4 0.0007
490 SUBARACHNOID HAEMORRHAGE 7 0.0007
491 CAESAREAN SECTION 8 0.0007
492 PHYSICAL DISABILITY 3 0.0007
493 RESPIRATORY RATE INCREASED 6 0.0007
494 CARDIO-RESPIRATORY ARREST 28 0.0007
495 ACUTE KIDNEY INJURY 101 0.0007
496 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
497 NEPHROGENIC ANAEMIA 3 0.0006
498 BRAIN DEATH 2 0.0006
499 PSYCHOTIC DISORDER 19 0.0006
500 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
501 ANAPHYLACTIC REACTION 35 0.0006
502 AGGRESSION 31 0.0006
503 LIVER ABSCESS 2 0.0006
504 BACTERIAL SEPSIS 2 0.0006
505 MYOCARDITIS 7 0.0006
506 LEUKOCYTOSIS 11 0.0006
507 HYPERVOLAEMIA 3 0.0006
508 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 2 0.0006
509 OXYGEN SATURATION DECREASED 34 0.0006
510 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
511 ELECTROLYTE IMBALANCE 7 0.0006
512 COAGULOPATHY 10 0.0006
513 HYPERAMMONAEMIA 3 0.0006
514 SALIVARY HYPERSECRETION 6 0.0006
515 KLEBSIELLA INFECTION 3 0.0006
516 TOXICITY TO VARIOUS AGENTS 100 0.0006
517 BK VIRUS INFECTION 2 0.0006
518 FEEDING DISORDER 12 0.0006
519 AMMONIA INCREASED 3 0.0006
520 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
521 ACUTE SINUSITIS 1 0.0006
522 FOETAL EXPOSURE DURING PREGNANCY 47 0.0006
523 TRANSFUSION 6 0.0006
524 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
525 TUMOUR LYSIS SYNDROME 5 0.0006
526 LUNG INFILTRATION 5 0.0006
527 SINUS TACHYCARDIA 8 0.0006
528 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
529 CAROTID ARTERY OCCLUSION 2 0.0005
530 MOUTH HAEMORRHAGE 4 0.0005
531 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
532 HEPATIC NECROSIS 2 0.0005
533 MYOCARDIAL ISCHAEMIA 6 0.0005
534 HALLUCINATION, VISUAL 11 0.0005
535 SEPSIS 58 0.0005
536 HAEMOLYSIS 4 0.0005
537 OFF LABEL USE 451 0.0005
538 EJECTION FRACTION DECREASED 8 0.0005
539 RHINOVIRUS INFECTION 2 0.0005
540 ACUTE HEPATIC FAILURE 7 0.0005
541 RENAL TUBULAR NECROSIS 5 0.0005
542 PNEUMONIA FUNGAL 2 0.0005
543 ANAPHYLACTIC SHOCK 13 0.0005
544 BLOOD POTASSIUM DECREASED 15 0.0005
545 HEPATOTOXICITY 11 0.0005
546 HYPERGLYCAEMIA 18 0.0005
547 ACCIDENTAL OVERDOSE 18 0.0005
548 SHOCK HAEMORRHAGIC 4 0.0005
549 ASPARTATE AMINOTRANSFERASE INCREASED 26 0.0005
550 LARYNGEAL OEDEMA 3 0.0005
551 EXTRAVASATION 2 0.0005
552 HEART RATE DECREASED 17 0.0005
553 FEBRILE NEUTROPENIA 32 0.0005
554 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
555 RHABDOMYOLYSIS 20 0.0005
556 BRAIN OEDEMA 6 0.0005
557 MYDRIASIS 6 0.0005
558 HEPATITIS ACUTE 3 0.0005
559 TOOTH INJURY 2 0.0005
560 ORTHOSTATIC HYPOTENSION 8 0.0005
561 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
562 HYPOGAMMAGLOBULINAEMIA 3 0.0005
563 HYPOKALAEMIA 21 0.0005
564 PNEUMONITIS 12 0.0004
565 RESTLESS LEGS SYNDROME 8 0.0004
566 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
567 EYE MOVEMENT DISORDER 3 0.0004
568 RESPIRATORY ARREST 12 0.0004
569 UROSEPSIS 4 0.0004
570 HYPERKALAEMIA 15 0.0004
571 SEIZURE 49 0.0004
572 DRUG LEVEL INCREASED 7 0.0004
573 PRE-ECLAMPSIA 2 0.0004
574 PARALYSIS 6 0.0004
575 RENAL IMPAIRMENT 35 0.0004
576 GASTROINTESTINAL TOXICITY 2 0.0004
577 DRUG-INDUCED LIVER INJURY 13 0.0004
578 THERAPY CHANGE 4 0.0004
579 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
580 PARANOIA 7 0.0004
581 BREATH SOUNDS ABNORMAL 2 0.0004
582 MUCOUS STOOLS 2 0.0004
583 DISORIENTATION 16 0.0004
584 FLUID INTAKE REDUCED 2 0.0004
585 BLOOD CREATININE INCREASED 26 0.0004
586 MOTOR DYSFUNCTION 4 0.0004
587 LIPASE INCREASED 3 0.0004
588 ABDOMINAL INFECTION 1 0.0004
589 PROCEDURAL COMPLICATION 3 0.0004
590 INTERCEPTED PRODUCT ADMINISTRATION ERROR 3 0.0004
591 ATRIAL FIBRILLATION 38 0.0004
592 FEMORAL NECK FRACTURE 2 0.0004
593 PRODUCT COLOUR ISSUE 2 0.0004
594 PERICARDIAL EFFUSION 9 0.0004
595 CEREBRAL ISCHAEMIA 2 0.0004
596 ATRIOVENTRICULAR BLOCK 3 0.0004
597 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
598 LUNG INFECTION 6 0.0004
599 RESTLESSNESS 14 0.0004
600 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
601 NYSTAGMUS 2 0.0004
602 THROMBOCYTOPENIA 42 0.0004
603 LACTIC ACIDOSIS 12 0.0004
604 BEHAVIOUR DISORDER 2 0.0004
605 RESPIRATORY DISORDER 11 0.0004
606 POST PROCEDURAL COMPLICATION 7 0.0004
607 INTESTINAL ISCHAEMIA 2 0.0004
608 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
609 EPILEPSY 11 0.0004
610 INTRACRANIAL PRESSURE INCREASED 2 0.0004
611 HAEMODIALYSIS 3 0.0004
612 DRUG USE DISORDER 3 0.0004
613 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
614 NEPHROPATHY TOXIC 4 0.0004
615 PREMATURE LABOUR 2 0.0004
616 HEPATOCELLULAR INJURY 5 0.0004
617 TREATMENT FAILURE 29 0.0003
618 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
619 NEUROLOGICAL SYMPTOM 2 0.0003
620 HEPATIC FUNCTION ABNORMAL 13 0.0003
621 HAEMATOMA 9 0.0003
622 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
623 METASTASES TO LUNG 4 0.0003
624 PYELONEPHRITIS 3 0.0003
625 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
626 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
627 PRODUCT USE IN UNAPPROVED INDICATION 84 0.0003
628 CARDIOMYOPATHY 5 0.0003
629 PERITONITIS 7 0.0003
630 ARRHYTHMIA 16 0.0003
631 COMA 16 0.0003
632 HEPATITIS CHOLESTATIC 2 0.0003
633 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
634 PLEURAL EFFUSION 20 0.0003
635 CEREBRAL INFARCTION 8 0.0003
636 HYPERTENSION 69 0.0003
637 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
638 SMALL INTESTINAL OBSTRUCTION 4 0.0003
639 PRODUCT PRESCRIBING ISSUE 7 0.0003
640 POISONING 4 0.0003
641 HYPOCALCAEMIA 6 0.0003
642 ABDOMINAL ADHESIONS 1 0.0003
643 CONDITION AGGRAVATED 96 0.0003
644 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
645 HALLUCINATION, AUDITORY 5 0.0003
646 RASH MACULO-PAPULAR 7 0.0003
647 RECALLED PRODUCT ADMINISTERED 3 0.0003
648 SCREAMING 2 0.0003
649 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 9 0.0003
650 BLOOD PRESSURE DECREASED 20 0.0003
651 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
652 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
653 DRUG INEFFECTIVE 391 0.0003
654 POSTOPERATIVE WOUND INFECTION 2 0.0003
655 DYSKINESIA 12 0.0003
656 EYELID PTOSIS 3 0.0003
657 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
658 AKATHISIA 4 0.0003
659 NEUTROPHIL COUNT INCREASED 3 0.0003
660 LYMPHOEDEMA 2 0.0003
661 NERVOUS SYSTEM DISORDER 9 0.0003
662 EXTRASYSTOLES 2 0.0003
663 DUODENAL ULCER 2 0.0003
664 IRRITABILITY 17 0.0003
665 DIALYSIS 4 0.0003
666 BRONCHOSPASM 4 0.0003
667 ISCHAEMIC STROKE 5 0.0003
668 BREAST CANCER METASTATIC 3 0.0003
669 HYPERSOMNIA 8 0.0003
670 DECREASED ACTIVITY 3 0.0003
671 END STAGE RENAL DISEASE 5 0.0003
672 HYPOPHOSPHATAEMIA 2 0.0003
673 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
674 STEVENS-JOHNSON SYNDROME 6 0.0003
675 URINARY RETENTION 9 0.0003
676 RENAL FAILURE 35 0.0003
677 BLOOD BILIRUBIN INCREASED 7 0.0003
678 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
679 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
680 PALLOR 7 0.0003
681 SWOLLEN TONGUE 8 0.0003
682 HAEMORRHAGIC STROKE 2 0.0003
683 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
684 CONFUSIONAL STATE 41 0.0003
685 DRUG SCREEN POSITIVE 2 0.0003
686 TRICUSPID VALVE INCOMPETENCE 2 0.0003
687 ATRIAL FLUTTER 2 0.0003
688 POLYNEUROPATHY 3 0.0003
689 TRANSPLANT REJECTION 2 0.0002
690 BLOOD DISORDER 2 0.0002
691 CYTOPENIA 3 0.0002
692 LUNG DISORDER 12 0.0002
693 ANAPHYLACTOID REACTION 1 0.0002
694 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
695 GENERALISED OEDEMA 3 0.0002
696 EXTRAPYRAMIDAL DISORDER 6 0.0002
697 ACUTE CORONARY SYNDROME 2 0.0002
698 BLOOD UREA INCREASED 4 0.0002
699 ASCITES 7 0.0002
700 COLITIS 9 0.0002
701 HEMIPARESIS 4 0.0002
702 INTENTIONAL OVERDOSE 15 0.0002
703 SCAR 4 0.0002
704 DRUG RESISTANCE 6 0.0002
705 PANCYTOPENIA 13 0.0002
706 HIATUS HERNIA 3 0.0002
707 MULTI-ORGAN FAILURE 4 0.0002
708 URINE OUTPUT DECREASED 2 0.0002
709 GROIN PAIN 2 0.0002
710 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
711 PURPURA 2 0.0002
712 DRUG ERUPTION 4 0.0002
713 TRANSAMINASES INCREASED 5 0.0002
714 CARDIAC FAILURE 18 0.0002
715 HAEMARTHROSIS 2 0.0002
716 ANAL INCONTINENCE 2 0.0002
717 HEPATIC ENZYME INCREASED 15 0.0002
718 PYREXIA 76 0.0002
719 SKIN LESION 6 0.0002
720 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
721 HYPERHIDROSIS 28 0.0002
722 GRAND MAL CONVULSION 2 0.0002
723 DRUG ABUSE 18 0.0002
724 COMPLETED SUICIDE 18 0.0002
725 DEEP VEIN THROMBOSIS 14 0.0002
726 COORDINATION ABNORMAL 3 0.0002
727 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
728 SUBDURAL HAEMATOMA 3 0.0002
729 SOMNOLENCE 42 0.0002
730 LETHARGY 12 0.0002
731 FLUID OVERLOAD 3 0.0002
732 ORAL HERPES 4 0.0002
733 OVERDOSE 44 0.0002
734 HAEMORRHAGE INTRACRANIAL 3 0.0002
735 HALLUCINATION 15 0.0002
736 HEPATIC FAILURE 6 0.0002
737 ECONOMIC PROBLEM 3 0.0002
738 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
739 NEPHROLITHIASIS 9 0.0002
740 CRYING 7 0.0002
741 DERMATITIS 4 0.0002
742 CYANOSIS 3 0.0002
743 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
744 NO ADVERSE EVENT 34 0.0002
745 HYPOGLYCAEMIA 9 0.0002
746 ANAL ABSCESS 1 0.0002
747 MUSCLE TIGHTNESS 3 0.0002
748 BLOOD POTASSIUM INCREASED 3 0.0002
749 SLEEP DISORDER 13 0.0002
750 BIPOLAR DISORDER 2 0.0002
751 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
752 PNEUMONIA 59 0.0002
753 PRODUCT USE ISSUE 34 0.0002
754 NERVE INJURY 2 0.0002
755 BLOOD CALCIUM DECREASED 2 0.0002
756 CANDIDA INFECTION 3 0.0002
757 MITRAL VALVE INCOMPETENCE 2 0.0002
758 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
759 MUSCLE TWITCHING 4 0.0002
760 LIVER FUNCTION TEST ABNORMAL 5 0.0002
761 DISEASE PROGRESSION 20 0.0002
762 PULMONARY EMBOLISM 16 0.0002
763 RENAL INJURY 5 0.0002
764 CHOLECYSTITIS 2 0.0002
765 DISTURBANCE IN ATTENTION 9 0.0002
766 GASTROENTERITIS VIRAL 3 0.0002
767 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
768 NO THERAPEUTIC RESPONSE 2 0.0002
769 RECTAL HAEMORRHAGE 7 0.0002
770 CARDIOMEGALY 2 0.0002
771 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
772 THINKING ABNORMAL 3 0.0002
773 HYPONATRAEMIA 9 0.0002
774 LIVER DISORDER 7 0.0002
775 PROTEINURIA 3 0.0002
776 SLEEP APNOEA SYNDROME 3 0.0002
777 HEPATIC CYTOLYSIS 2 0.0002
778 HYPOPHAGIA 4 0.0002
779 HEPATITIS 4 0.0002
780 THERAPY CESSATION 8 0.0002
781 DRUG INTOLERANCE 15 0.0002
782 NEUTROPENIA 21 0.0002
783 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
784 PRODUCT ADMINISTRATION ERROR 3 0.0001
785 SUICIDE ATTEMPT 9 0.0001
786 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
787 DISCOMFORT 9 0.0001
788 BODY TEMPERATURE INCREASED 3 0.0001
789 GINGIVAL BLEEDING 2 0.0001
790 RASH ERYTHEMATOUS 7 0.0001
791 PRODUCT PREPARATION ERROR 3 0.0001
792 MEDICATION ERROR 8 0.0001
793 HYPOMAGNESAEMIA 2 0.0001
794 APHONIA 2 0.0001
795 PLATELET COUNT DECREASED 15 0.0001
796 SYNCOPE 14 0.0001
797 IMPAIRED QUALITY OF LIFE 2 0.0001
798 MYELOSUPPRESSION 5 0.0001
799 HYPOKINESIA 2 0.0001
800 PRODUCT DISPENSING ERROR 3 0.0001
801 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
802 APATHY 2 0.0001
803 DYSPHAGIA 13 0.0001
804 ACUTE MYOCARDIAL INFARCTION 4 0.0001
805 ANGIOEDEMA 6 0.0001
806 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
807 CHROMATURIA 3 0.0001
808 DYSARTHRIA 5 0.0001
809 LOSS OF CONSCIOUSNESS 17 0.0001
810 MUSCULAR WEAKNESS 15 0.0001
811 DEVICE FAILURE 2 0.0001
812 HEART RATE INCREASED 13 0.0001
813 ANAEMIA 25 0.0001
814 DRUG DEPENDENCE 21 0.0001
815 DEVICE RELATED INFECTION 2 0.0001
816 CONSTIPATION 28 0.0001
817 ACUTE MYELOID LEUKAEMIA 2 0.0001
818 TREATMENT NONCOMPLIANCE 7 0.0001
819 ULCER 2 0.0001
820 INTENTIONAL PRODUCT MISUSE 11 0.0001
821 OBESITY 2 0.0001
822 COVID-19 22 0.0001
823 ABSCESS 2 0.0001
824 DIABETIC KETOACIDOSIS 3 0.0001
825 PRESYNCOPE 3 0.0001
826 AMNESIA 8 0.0001
827 EYE DISORDER 4 0.0001
828 MANIA 2 0.0001
829 STAPHYLOCOCCAL INFECTION 4 0.0001
830 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
831 LEUKOPENIA 6 0.0001
832 CHRONIC KIDNEY DISEASE 9 0.0001
833 URINARY TRACT INFECTION 20 0.0001
834 HAEMATURIA 4 0.0001
835 EOSINOPHILIA 2 0.0001
836 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
837 FEAR 3 0.0001
838 JAUNDICE 3 0.0001
839 BLOOD PRESSURE INCREASED 17 0.0001
840 BLOOD GLUCOSE ABNORMAL 2 0.0001
841 PROCEDURAL PAIN 3 0.0001
842 BACTERIAL INFECTION 2 0.0001
843 HAEMORRHAGE 11 0.0001
844 ANGINA PECTORIS 3 0.0001
845 PULMONARY FIBROSIS 2 0.0001
846 AFFECT LABILITY 1 0.0001
847 INTERSTITIAL LUNG DISEASE 5 0.0001
848 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
849 DYSPHONIA 6 0.0001
850 DISABILITY 2 0.0001
851 SPINAL FRACTURE 2 0.0001
852 FLUID RETENTION 5 0.0001
853 BLINDNESS 4 0.0001
854 NEUTROPHIL COUNT DECREASED 4 0.0001
855 DYSPNOEA 54 0.0001
856 PANCREATITIS 5 0.0001
857 MOVEMENT DISORDER 3 0.0001
858 NIGHT SWEATS 3 0.0001
859 FAECES DISCOLOURED 2 0.0001
860 ANXIETY 26 0.0001
861 VOMITING 42 0.0001
862 RASH PAPULAR 2 0.0001
863 PANCREATITIS ACUTE 2 0.0001
864 CEREBROVASCULAR ACCIDENT 15 0.0001
865 CARDIAC FAILURE CONGESTIVE 7 0.0001
866 TINNITUS 4 0.0001
867 ABDOMINAL DISTENSION 9 0.0001
868 INJURY 6 0.0001
869 CHILLS 10 0.0001
870 DISEASE RECURRENCE 4 0.0001
871 CEREBRAL HAEMORRHAGE 3 0.0001
872 PRODUCTIVE COUGH 4 0.0001
873 ACCIDENT 1 0.0001
874 BLOOD PRESSURE FLUCTUATION 2 0.0001
875 DEHYDRATION 11 0.0001
876 THERAPEUTIC RESPONSE DECREASED 5 0.0001
877 OEDEMA PERIPHERAL 10 0.0001
878 HAEMATEMESIS 2 0.0001
879 DIPLOPIA 2 0.0001
880 INFUSION RELATED REACTION 5 0.0001
881 ADVERSE REACTION 1 0.0001
882 THROMBOSIS 6 0.0001
883 THROAT TIGHTNESS 2 0.0001
884 RASH PRURITIC 4 0.0001
885 TREMOR 12 0.0001
886 DIVERTICULITIS 2 0.0001
887 DEVICE MALFUNCTION 5 0.0001
888 MUSCULOSKELETAL STIFFNESS 6 0.0001
889 CHEST DISCOMFORT 7 0.0001
890 PALPITATIONS 8 0.0001
891 HAEMOGLOBIN DECREASED 7 0.0001
892 WHEEZING 4 0.0001
893 APHASIA 2 0.0001
894 STOMATITIS 4 0.0001
895 URTICARIA 11 0.0001
896 CHEST PAIN 12 0.0001
897 FEMUR FRACTURE 2 0.0001
898 COGNITIVE DISORDER 3 0.0001
899 HYPOTHYROIDISM 2 0.0001
900 SWELLING FACE 4 0.0001
901 DRY EYE 3 0.0001
902 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
903 NIGHTMARE 2 0.0001
904 PAIN 35 0.0001
905 THERAPY INTERRUPTED 4 0.0001
906 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
907 OEDEMA 3 0.0001
908 RASH 24 0.0001
909 AGRANULOCYTOSIS 1 0.0001
910 COUGH 15 0.0001
911 EPISTAXIS 4 0.0001
912 BLISTER 3 0.0001
913 DYSPNOEA EXERTIONAL 2 0.0001
914 NAUSEA 42 0.0001
915 INTESTINAL OBSTRUCTION 2 0.0001
916 HOSPITALISATION 8 0.0001
917 ABDOMINAL PAIN 12 0.0001
918 PRODUCT QUALITY ISSUE 7 0.0001
919 ABNORMAL BEHAVIOUR 2 0.0001
920 DEATH 43 0.0000
921 RHINORRHOEA 3 0.0000
922 VAGINAL HAEMORRHAGE 2 0.0000
923 PRODUCT STORAGE ERROR 4 0.0000
924 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
925 ADVERSE DRUG REACTION 4 0.0000
926 MUSCLE SPASMS 8 0.0000
927 ADVERSE EVENT 4 0.0000
928 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
929 SWELLING 4 0.0000
930 NEUROPATHY PERIPHERAL 4 0.0000
931 SKIN BURNING SENSATION 3 0.0000
932 BLOOD GLUCOSE DECREASED 2 0.0000
933 EMOTIONAL DISTRESS 5 0.0000
934 INSOMNIA 11 0.0000
935 ABDOMINAL PAIN LOWER 1 0.0000
936 FLUSHING 4 0.0000
937 FALL 13 0.0000
938 ERYTHEMA 8 0.0000
939 INFLAMMATION 2 0.0000
940 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
941 ECZEMA 2 0.0000
942 SPEECH DISORDER 2 0.0000
943 DRUG EFFECT DECREASED 2 0.0000
944 DRY MOUTH 3 0.0000
945 VISION BLURRED 5 0.0000
946 HAEMATOCHEZIA 2 0.0000
947 ABNORMAL DREAMS 1 0.0000
948 EYE PAIN 2 0.0000
949 PRODUCT SUBSTITUTION ISSUE 2 0.0000
950 ASTHENIA 13 0.0000
951 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
952 DIARRHOEA 22 0.0000
953 DEVICE ISSUE 3 0.0000
954 HYPOAESTHESIA 5 0.0000
955 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
956 ILL-DEFINED DISORDER 2 0.0000
957 VERTIGO 2 0.0000
958 SUICIDAL IDEATION 3 0.0000
959 OROPHARYNGEAL PAIN 3 0.0000
960 CARDIAC DISORDER 3 0.0000
961 PARAESTHESIA 5 0.0000
962 ANGER 1 0.0000
963 MEMORY IMPAIRMENT 4 0.0000
964 PRURITUS 11 0.0000
965 DIZZINESS 14 0.0000
966 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
967 FATIGUE 21 0.0000
968 HYPERSENSITIVITY 5 0.0000
969 UNEVALUABLE EVENT 2 0.0000
970 DIABETES MELLITUS 2 0.0000
971 HEADACHE 16 0.0000
972 VISUAL IMPAIRMENT 3 0.0000
973 INCORRECT DOSE ADMINISTERED 5 0.0000
974 WEIGHT DECREASED 6 0.0000
975 BLOOD GLUCOSE INCREASED 4 0.0000
976 ABDOMINAL PAIN UPPER 4 0.0000
977 DEPRESSION 4 0.0000
978 DECREASED APPETITE 4 0.0000
979 BACK PAIN 4 0.0000
980 JOINT SWELLING 2 0.0000
981 GAIT DISTURBANCE 3 0.0000
982 ARTHRALGIA 6 0.0000
983 INFECTION 2 0.0000
984 PAIN IN EXTREMITY 4 0.0000
985 FEELING ABNORMAL 3 0.0000
986 MYALGIA 2 0.0000
987 ALOPECIA 2 0.0000
988 MALAISE 4 0.0000
989 INJECTION SITE PAIN 2 0.0000
990 ABDOMINAL DISCOMFORT 1 0.0000